Start Codon leverages the unique resources of the Cambridge Cluster to identify, seed-fund and drive the success of truly disruptive healthcare start-ups.
STEMCELL Technologies is a leader in the development of specialty cell culture media, cell separation products and accessory reagents for life science research. Driven by science and a passion for quality, STEMCELL delivers over 1500 products to more than 70 countries worldwide. To learn more, visit https://www.stemcell.com
No data available
Targeting pathways that modify RNA to deliver novel cancer therapeutics
Stratagem IPM was formed in 1999 to respond to a developing need within the biotech industry for clear and decisive strategic Intellectual Property advice. From its original biotech foundation, Stratagem now has commercially trained IP experts with first-hand experience in many industries, working with a wide range of clients, from start-ups and SMEs to multi-national companies.
With a Head Office in Cambridge, we deliver a strategically different IP management service for our clients, operating as though we are part of their business and using our hands-on management approach to ensure they are able to protect, exploit, and enhance the value of their IP assets and portfolios. We are dedicated to providing comprehensive intellectual property advice in the UK and internationally.
With a Head Office in Cambridge, we deliver a strategically different IP management service for our clients, operating as though we are part of their business and using our hands-on management approach to ensure they are able to protect, exploit, and enhance the value of their IP assets and portfolios. We are dedicated to providing comprehensive intellectual property advice in the UK and internationally.
Sygnature Discovery, founded in 2004 in Nottingham, UK, is a leading independent provider of integrated drug discovery and pre-clinical resource and expertise. We undertake target validation, hit identification, hit-to-lead and lead optimisation projects and complete drug discovery programs. We offer fully integrated discovery project support, as well as discipline specific support in chemistry, computational sciences, in vitro biology, DMPK or in vivo pharmacology as needed by our collaborating clients. Sygnature adds significant value to collaborations by providing advanced scientific knowledge and intellectual input to accelerate clients’ drug discovery projects from target validation and lead optimisation through to pre-clinical candidate. Since 2011, 31 compounds discovered by Sygnature for clients have entered pre-clinical development and so far, 15 of these have progressed to clinical trials (Phases I, II and III). A multi award-winning company, Sygnature operates fully enabled research facilities in Nottingham and Alderley Park, UK, housing the most technologically advanced laboratories and teams of expert scientists (>80% with PhDs). For additional information, go to: https://www.sygnaturediscovery.com
Symbiosis IP is a patent attorney and professional services firm primarily serving the life science industry. We have a wealth of experience in working closely with corporate clients, start-up companies and academic institutions. This experience enables us to protect, develop and commercialise IP that drives new businesses forward whatever their complexity. Our team of patent attorneys all have higher degrees in a Life Science or chemical subject, and we all have post-doctoral research experience which we believe adds value to our clients’ intellectual property. In addition to prosecution of patent applications Symbiosis’ attorneys have direct experience of opposition and appeal proceedings. Our team of IP and innovation experts can support every aspect of IP commercialisation, including strategy, policy review and benchmarking, patent landscaping, market assessment, technology marketing, IP valuation, and licensing & transaction support. We are a trusted, independent partner and our team includes highly experienced ex-industry, university technology transfer and IP specialists with a wealth of real hands-on experience, global contacts and practical consulting experience. Together, our priority is to develop long-lasting, mutually beneficial professional relationships that maximise the benefit that your technology can bring to your business. Visit our website: https://www.symbiosisip.co.uk
Syngene is a contract research, development and manufacturing organization (CRDMO) that provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer goods and agrochemical companies.
Syngene’s clients are world leaders in their fields, ranging from leading global multinationals to small and medium-sized start-ups, non-profit institutions, academic institutes and government organizations.
Syngene’s clients are world leaders in their fields, ranging from leading global multinationals to small and medium-sized start-ups, non-profit institutions, academic institutes and government organizations.
A stem cell drug discovery company
Taylor Wessing LLP has offices in London and Cambridge and is a leading international law firm with 22 offices in Europe, the Middle East and Asia. We advise life science businesses, those who fund them and those who work for them. Our extensive Life Sciences Group combines lawyers from Taylor Wessing’s intellectual property, corporate, competition, dispute resolution and employment practices. The Group in the UK includes 15 lawyers with first degrees in life sciences subjects, of whom several have PhDs and many have spent periods working in the biotech and pharmaceutical industry.